2018 Annual Report & Accounts

RNS Number : 3078R

ConvaTec Group PLC

27 February 2019

 

2018 Annual Report & Accounts

READING, UNITED KINGDOM (27 February 2019) - ConvaTec Group Plc ("ConvaTec" or the "Group"), a leading global medical products and technologies company, has today published on the Group's website its Annual Report & Accounts for the year ended 31 December 2018 (the "Annual Report").  The Annual Report is available at www.convatecgroup.com.

In compliance with Listing Rule 9.6.1, a copy of the Annual Report will also shortly be submitted to the National Storage Mechanism and will be available for inspection at www.morningstar.co.uk/uk/NSM.

The Annual Report, together with notice of the Group's Annual General Meeting to be held on 9 May 2019, will be sent to shareholders in due course, at which point a further announcement will be made.

About ConvaTec

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. Our products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com.

Enquiries

Media

Bobby Leach, VP Group Corporate Affairs, ConvaTec                     [phone]

Finsbury                                                                                            [phone]

Analysts and Investors

John Crosse, VP Investor Relations, ConvaTec                             [phone]

Mark Reynolds, Director Investor Relations, ConvaTec                 [phone]

[e-mail]

ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92

# # #

END

 

END

 

 

ACSFMGZZZNMGLZM